Enhanced Anti‐Tumour Efficacy of iRGD‐Modified Cell‐Bound Membrane Vesicles (iRGD‐CBMVs) as a Novel Drug Carrier
ABSTRACT Cancer continues to be the foremost cause of mortality in humans. Persistent challenges in cancer treatment include inadequate drug targeting, severe toxicological side effects and uncontrolled drug distribution. The bioinspired membrane vesicle drug delivery systems have been emerging as p...
Saved in:
| Main Authors: | Haonan Zhao, Zhendong Huang, Qinghua Sheng, Wenxiang Shao, Min Zeng, Kun Wang, Yang Zhang, Ying Qin, Zhihao Xiong, Lizhen Chen, Huaying Wang, Tong Rong, Zhitao Qiu, Hongda Zhuang, Zhiwen Wu, Yuan Zhang, Wendiao Zhang, Yong Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | Journal of Extracellular Biology |
| Online Access: | https://doi.org/10.1002/jex2.70052 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: Anticancer activity of Pseudomonas aeruginosa derived peptide with iRGD in colon cancer therapy
Published: (2025-07-01) -
Tumor-specific delivery of KRAS siRNA with iRGD-exosomes efficiently inhibits tumor growth
by: Yu Zhou, et al.
Published: (2019-12-01) -
Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activation
by: Jie Shao, et al.
Published: (2024-12-01) -
Enhancing doxorubicin sensitivity in osteosarcoma via iRGD-modified biomimetic nanoparticles targeting MCAM m6A modification
by: Dongjian Song, et al.
Published: (2025-07-01) -
Design and synthesis of hydrophobic RGD-peptides derivatives
by: A. V. Dobrynina, et al.
Published: (2010-02-01)